Clinical Trials Logo

Severe Alzheimer Disease clinical trials

View clinical trials related to Severe Alzheimer Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03765762 Completed - Clinical trials for Severe Alzheimer Disease

A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease

Start date: January 15, 2019
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety, tolerability, and potential cognitive benefit of the experimental treatment GRF6019 in subjects with severe Alzheimer's disease.